E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation

Oncogene

Volumn 26, Issue 3, 2007, Pages 441-448

  Sun, L ^a   Trausch Azar, J S ^a   Ciechanover, A ^b   Schwartz, A L ^a,c  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

E12; E2A; E47; Muscle differentiation; Proteasome; Ubiquitin

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME; PROTEASOME INHIBITOR; TRANSCRIPTION FACTOR E2A; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; DEVELOPMENTAL STAGE; FEMALE; HUMAN; HUMAN CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; TRANSLATION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HELIX-LOOP-HELIX MOTIFS; HUMANS; MICE; MUSCLE FIBERS; MYOBLASTS; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION, GENETIC; UBIQUITIN;

EID: 33846315989     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209793     Document Type: Article

References (26)

1. Aronheim A, Shiran R, Rosen A, Walker MD. (1993). Proc Natl Acad Sci USA 90: 8063-8067.
2. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC et al. (1994). Cell 79: 885-892.
3. Coulombe P, Rodier G, Pelletier S, Pellerin J, Meloche S. (2003). Mol Cell Biol 23: 4542-4558.
4. Dearth LR, DeWille J. (2003). J Biol Chem 278: 11246-11255.
5. Deed RW, Armitage S, Norton JD. (1996). J Biol Chem 271: 23603-23606.
6. Guillemot F, Lo LC, Johnson JE, Auerbach A, Anderson DJ, Joyner AL. (1993). Cell 75: 463-476.
7. Hsu HL, Cheng JT, Chen Q, Baer R. (1991). Mol Cell Biol 11: 3037-3042.
8. Huggins GS, Chin MT, Sibinga NE, Lee SL, Haber E, Lee ME. (1999). J Biol Chem 274: 28690-28696.
9. Kho CJ, Huggins GS, Endege WO, Hsieh CM, Lee ME, Haber E. (1997). J Biol Chem 272: 3845-3851.
10. Langlands K, Yin X, Anand G, Prochownik EV. (1997). J Biol Chem 272: 19785-19793.
11. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A et al. (1991). Cell 66: 305-315.
12. Lazorchak A, Jones ME, Zhuang Y. (2005). Trends Immunol 26: 334-338.
13. Lingbeck JM, Trausch-Azar JS, Ciechanover A, Schwartz AL. (2005). Oncogene 24: 6376-6384.
14. Lluis F, Ballestar E, Suelves M, Esteller M, Munoz-Canoves P. (2005). EMBO J 24: 974-984.
15. Nie L, Xu M, Vladimirova A, Sun XH. (2003). EMBO J 22: 5780-5792.
16. Peverali FA, Ramqvist T, Saffrich R, Pepperkok R, Barone MV, Philipson L. (1994). EMBO J 13: 4291-4301.
17. Quong MW, Romanow WJ, Murre C. (2002). Annu Rev Immunol 20: 301-322.
18. Riera L, Obach M, Navarro-Sabate A, Duran J, Perales J C, Vinals F et al. (2003). FEBS Lett 550: 23-29.
19. Riley RL, Van der Put E, King AM, Frasca D, Blomberg BB. (2005). Semin Immunol 17: 330-336.
20. Roberts VJ, Steenbergen R, Murre C. (1993). Proc Natl Acad Sci USA 90: 7583-7587.
21. Sun L, Trausch-Azar JS, Ciechanover A, Schwartz AL. (2005). J Biol Chem 280: 26448-26456.
22. Sun XH, Baltimore D. (1991). Cell 64: 459-470.
23. Van der Put E, Frasca D, King AM, Blomberg BB, Riley RL. (2004). J Immunol 173: 818-827.
24. Voronova A, Baltimore D. (1990). Proc Natl Acad Sci USA 87: 4722-4726.
25. Weintraub H. (1993). Cell 75: 1241-1244.
26. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y. (1997). Mol Cell Biol 17: 7317-7327.